OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current status and new developments in sphingosine-1-phosphate receptor antagonism: fingolimod and more
Victor Constantinescu, Katja Akgün, Tjalf Ziemssen
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 10, pp. 675-693
Closed Access | Times Cited: 11
Victor Constantinescu, Katja Akgün, Tjalf Ziemssen
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 10, pp. 675-693
Closed Access | Times Cited: 11
Showing 11 citing articles:
The role of sphingosine-1-phosphate in autophagy and related disorders
Siqi Xiao, Kaixin Peng, C.-L. Li, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Siqi Xiao, Kaixin Peng, C.-L. Li, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
The Potential Capacities of FTY720: Novel Therapeutic Functions, Targets, and Mechanisms against Diseases
Juan Liu, Lu Zhang, Le Liu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117508-117508
Open Access
Juan Liu, Lu Zhang, Le Liu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117508-117508
Open Access
FTY720 alleviates HBV-mediated inflammatory liver injury through a dual role of inhibiting lymphocyte trafficking and viral replication
Juan Liu, Yinxia Zhao, Ya‐Hui Song, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114495-114495
Closed Access
Juan Liu, Yinxia Zhao, Ya‐Hui Song, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114495-114495
Closed Access
1-Phosphate receptor agonists: A promising therapeutic avenue for ischemia-reperfusion injury management
Linyuan Wang, Xiaowen Zhang, Chunyan Ma, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111835-111835
Closed Access | Times Cited: 2
Linyuan Wang, Xiaowen Zhang, Chunyan Ma, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111835-111835
Closed Access | Times Cited: 2
Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis
Victor Constantinescu, Rocco Haase, Katja Akgün, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Victor Constantinescu, Rocco Haase, Katja Akgün, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer
Saïda Mebarek, Najwa Skafi, Leyre Brizuela
Cancers (2023) Vol. 15, Iss. 10, pp. 2732-2732
Open Access | Times Cited: 5
Saïda Mebarek, Najwa Skafi, Leyre Brizuela
Cancers (2023) Vol. 15, Iss. 10, pp. 2732-2732
Open Access | Times Cited: 5
Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial
Hong Zhang, Qianqian Li, Cuiyun Li, et al.
The Lancet Rheumatology (2024)
Closed Access | Times Cited: 1
Hong Zhang, Qianqian Li, Cuiyun Li, et al.
The Lancet Rheumatology (2024)
Closed Access | Times Cited: 1
Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis
Alisa V. Alessenko, У. А. Гутнер, Maria Shupik
Life (2023) Vol. 13, Iss. 2, pp. 510-510
Open Access | Times Cited: 4
Alisa V. Alessenko, У. А. Гутнер, Maria Shupik
Life (2023) Vol. 13, Iss. 2, pp. 510-510
Open Access | Times Cited: 4
Recent Insight into the Role of Sphingosine-1-Phosphate Lyase in Neurodegeneration
Iga Wieczorek, Robert P. Strosznajder
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6180-6180
Open Access | Times Cited: 4
Iga Wieczorek, Robert P. Strosznajder
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6180-6180
Open Access | Times Cited: 4
Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC)
Tjalf Ziemssen, Marie Groth, Veronika Winkelmann, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1374-1374
Open Access | Times Cited: 3
Tjalf Ziemssen, Marie Groth, Veronika Winkelmann, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1374-1374
Open Access | Times Cited: 3
Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis
Lena Höpner, Undine Proschmann, Hernán Inojosa, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Lena Höpner, Undine Proschmann, Hernán Inojosa, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Introduction to the neuroimmunology of multiple sclerosis
Niloufar Yazdanpanah, Nima Rezaei
Elsevier eBooks (2023), pp. 1-9
Closed Access
Niloufar Yazdanpanah, Nima Rezaei
Elsevier eBooks (2023), pp. 1-9
Closed Access
